Keros Therapeutics Surges 3.07% After $20M Milestone Announcement
Discover how Keros Therapeutics’ $20 M milestone from Takeda fuels a 3% stock lift and solid cash reserves—what it means for investors and future growth.
- KEROS THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read